Modelling the delay between pharmacokinetics and EEG effects of morphine in rats: binding kinetic versus effect compartment models

Journal of Pharmacokinetics and Pharmacodynamics
Wilhelmus E A de WitteElizabeth C M de Lange

Abstract

Drug-target binding kinetics (as determined by association and dissociation rate constants, kon and koff) can be an important determinant of the kinetics of drug action. However, the effect compartment model is used most frequently instead of a target binding model to describe hysteresis. Here we investigate when the drug-target binding model should be used in lieu of the effect compartment model. The utility of the effect compartment (EC), the target binding kinetics (TB) and the combined effect compartment-target binding kinetics (EC-TB) model were tested on either plasma (ECPL, TBPL and EC-TBPL) or brain extracellular fluid (ECF) (ECECF, TBECF and EC-TBECF) morphine concentrations and EEG amplitude in rats. It was also analyzed when a significant shift in the time to maximal target occupancy (TmaxTO) with increasing dose, the discriminating feature between the TB and EC model, occurs in the TB model. All TB models assumed a linear relationship between target occupancy and drug effect on the EEG amplitude. All three model types performed similarly in describing the morphine pharmacodynamics data, although the EC model provided the best statistical result. The analysis of the shift in TmaxTO (∆TmaxTO) as a result of increasing...Continue Reading

References

Dec 1, 1982·Journal of Autonomic Pharmacology·R R Ruffolo
Oct 1, 1994·Clinical Pharmacology and Therapeutics·W J Jusko, H C Ko
Aug 1, 1993·Journal of Pharmacokinetics and Biopharmaceutics·N L DaynekaW J Jusko
Feb 1, 1995·Journal of Pharmacokinetics and Biopharmaceutics·W J JuskoW F Ebling
Dec 1, 1996·NeuroImage·A A Lammertsma, S P Hume
Mar 7, 1998·British Journal of Clinical Pharmacology·M WakelkampG Paintaud
Oct 9, 2002·European Journal of Drug Metabolism and Pharmacokinetics·Graciela N Balerio, Modesto C Rubio
Mar 6, 2004·Journal of Pharmacokinetics and Pharmacodynamics·Liping ZhangLewis B Sheiner
Feb 11, 2005·The Journal of Pharmacology and Experimental Therapeutics·Ashraf YassenMeindert Danhof
Nov 25, 2005·Journal of Pharmacokinetics and Pharmacodynamics·Lambertus A PeletierJacintha den Haag
Dec 2, 2005·Journal of Pharmacokinetics and Pharmacodynamics·Matthew M HutmacherDavid C Jordan
Dec 6, 2005·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Lia C LiefaardRob A Voskuyl
Jul 13, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Angela AbelöMats O Karlsson
Aug 5, 2006·Nature Reviews. Drug Discovery·Robert A CopelandThomas D Meek
May 1, 2007·Clinical Pharmacokinetics·Ashraf YassenMeindert Danhof
Mar 3, 2009·Drug Metabolism and Pharmacokinetics·Bart A PloegerMeindert Danhof
Jul 29, 2010·Current Opinion in Chemical Biology·Hao Lu, Peter J Tonge
Apr 1, 2011·British Journal of Pharmacology·Simeon J RamseyPiet H van der Graaf
Feb 15, 2012·Naunyn-Schmiedeberg's Archives of Pharmacology·Georges VauquelinPhilip Seeman
Mar 19, 2013·Drug Discovery Today·Göran Dahl, Tomas Akerud
Apr 22, 2015·Nature Chemical Biology·Grant K WalkupStewart L Fisher
Aug 1, 2015·CPT: Pharmacometrics & Systems Pharmacology·P DuaP H van der Graaf
Oct 21, 2015·Expert Opinion on Drug Discovery·Wilhelmus E A de WitteElizabeth C M de Lange
Nov 3, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Xi-Ling JiangStephan Schmidt
Jan 27, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Kristoffer SahlholmPeter Århem
Jul 11, 2016·Trends in Pharmacological Sciences·Wilhelmus E A de WitteElizabeth C M de Lange
Dec 21, 2016·Frontiers in Physiology·David L I JanzénMichael J Chappell
Apr 17, 2017·Drug Discovery Today·Doris A SchuetzGerhard F Ecker

❮ Previous
Next ❯

Citations

May 17, 2019·Fluids and Barriers of the CNS·Esmée VendelElizabeth C M de Lange
Apr 9, 2021·Peptides·Richard J Bodnar

❮ Previous
Next ❯

Software Mentioned

NONMEM
RStudio

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.